baber/WOPTO huggingface dataset:
Patent NZ-230008-A (NZ)
Title: A carbon heat source for use in a smoking article characterised by it's shape
Inventor: NYSTROM WILLIAM ANTON
IPC: A24D1/22
Filed: 1989-07-20
Abstract: A carbonaceous heat source 20 for a smoking article 10 is provided. The heat source 20 is designed to maximize heat transfer to a flavor bed 21 in the smoking article 10. The heat source 20 undergoes substantially complete combustion leaving minimal residual ash, has a relatively low degree of thermal conductivity and ignites under normal lighting conditions for a conventional cigarette.
Patent NZ-230074-A (NZ)
Title: Transferring calibration data between measuring instruments
Inventor: REGIMAND ALI
IPC: G01N23/09
Filed: 1989-07-25
Abstract: The present invention provides a method and system which is useful on instruments requiring experimentally determined calibration curves by which calibration data can be transferred to a plurality of field gauges, thereby avoiding the necessity of individually calibrating each gauge each time calibration is necessary.
Patent NZ-230229-A (NZ)
Title: Human serum albumin (hsa) or one of its variants produced recombinantly in the yeast kluyveromyces
Inventor: FLEER REINHARD
IPC: C12R1/645
Filed: 1989-08-07
Abstract: Microbiological method for the preparation of human serum albumin and other heterologous (non-yeast) proteins by growing a yeast, especially of the genus Kluyveromyces, modified by the use of recombinant DNA techniques.
Patent NZ-230417-A (NZ)
Title: Glass block building panel assembly
Inventor: TAYLOR JOHN RICHARD
IPC: E04C2/54
Filed: 1989-08-24
Abstract: A glass block (14) panel construction and method of fabrication useful for decorative and functional purposes. The panel includes a frame (10) rigidly assembled from interlocking components (40,52) to form a grid-like pattern of adjacent pockets (12), each pocket (12) sized to receive and support a glass block (14) by way of support lips (39,50,60) extending around each pocket, the blocks (14) bonded to the frame (10) and therefore to one another in structurally stable and weather sealed relation. <IMAGE>
Patent NZ-232638-A (NZ)
Title: Removal of hypochlorite ions in a chlorate solution by hydrogen peroxide
Inventor: PRALUS CHRISTIAN
IPC: C25B15/08
Filed: 1990-02-22
Abstract: Destruction of hypochlorites in a perchlorate solution, without affecting hexavalent chromium if it is also present, using hydrogen peroxide.
Patent NZ-239653-A (NZ)
Title: Shrink bag with integral handle
Inventor: KUPCIKEVICIUS VYTAUTAS
IPC: B31B19/86
Filed: 1991-09-03
Abstract: A shrink bag having one end (24) heat sealed to form the closed end of a bag pocket and including a skirt portion at this closed end which forms a handle (42) upon heat shrinking the bag about a food product. The bag is particularly adapted for packaging whole turkeys and the like and, to this end, the heat seal is configured so the bag pocket closed end is a deep cavity shaped to accommodate the tail end of the turkey. <IMAGE>
Patent NZ-239826-A (NZ)
Title: Antibodies altered in the complementarity determining regions of the variable domain and their preparation
Inventor: GORMAN SCOTT DAVID
IPC: A61K39/395
Filed: 1991-09-17
Abstract: An altered antibody chain is produced in which the CDR's of the variable domain of the chain are derived from a first mammalian species. The framework-encoding regions of DNA encoding the variable domain of the first species are mutated so that the mutated framework-encoding regions encode a framework derived from a second different mammalian species. The or each constant domain of the antibody chain, if present, are also derived from the second mammalian species.
Patent NZ-242854-A (NZ)
Title: Reaction product of a calcium compound and citric acid, use as an anti-caking agent
Inventor: VIDAL SUSAN M
IPC: A23L1/00
Filed: 1992-05-21
Abstract: A new and useful calcium salt of citric acid is prepared and is used as an anticaking agent in furctose-sweetened powdered soft drinks. Also included are the processes for preparing the new calcium salt and powdered beverage mixes containing the new salt.
Patent NZ-250031-A (NZ)
Title: Animal feed comprising orthophosphate recovered from the treatment of animal flesh during slaughter
Inventor: BENDER FREDRIC GRANT
IPC: A23K1/175
Filed: 1993-10-22
Abstract: Phosphate is recovered from waste. Trialkali metal orthophosphate used to reduce, remove or retard bacterial contamination during raw meat slaughter including poultry, fish and shellfish and red meat evisceration is recovered from an aqueous waste and recycled as a food additive for animal feed. The waste water containing the phosphate can be collected and mixed with offal during processing of the offal or may be concentrated and blended with the offal as feed for animals or may be reacted with an alkaline earth metal salt and concentrated and used as a calcium and phosphate supplement for animal feed. Trisodium orthophosphate is reacted with calcium chloride and the resulting precipitate removed from the aqueous stream by filtration or centrifugation or other means for separation. The precipitate is then added to offal during processing for animal feed or dried sterilized and sold as an animal feed mineral supplement.
Patent NZ-265184-A (NZ)
Title: Water purifier: water irradiated with uv before and after passing through filter
Inventor: ENGELHARD ROLF
IPC: C02F9/00
Filed: 1994-04-05
Abstract: Water to be purified swirls about a source of ultraviolet radiation to kill any microorganisms contained therein and flows through a carbon filter cartridge mounted about the ultraviolet source to remove any chlorine and particulate matter. The outflow from the carbon filter is again subjected to ultraviolet radiation to kill any microorganisms entrained in the water emanating from the carbon filter. An ozone generator may be incorporated to entrain ozone with the inflowing water to enhance killing of any microorganisms present and to oxidize any undesirable compounds.
Patent NZ-272941-A (NZ)
Title: Use of 1-azabicyclo[2.2.2]octane derivatives for preparing medicaments
Inventor: ITO FUMITAKA
IPC: C07D453/02
Filed: 1992-05-22
Abstract: Compounds of formula (I), wherein W, Ar<1>, Ar<2> and Ar<3> are defined as below; and the pharmaceutically acceptable salts of such compounds. These compounds are substance P antagonists and useful in the treatment of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain.
Patent NZ-272946-A (NZ)
Title: Heteroaryl-n-oxide substituted benzoyl guanidines; pharmaceutical compositions
Inventor: KLEEMANN HEINZ-WERNER
IPC: C07D213/89
Filed: 1995-09-07
Abstract: Benzoyl guanidine derivs. of formula (I) and their salts are new: one of R1-R3 = Het (linked by C or N), SR10, OR10, NR10R11 or CR10R11R12; and the other two of R1-R3 = H, halo, CN, X(CH2)p(CqF2q+1), SOuR22, CONR23R24, COR25, SO2NR26R27, 1-8C alkyl, 2-8C alkenyl, CmH2mR14, OR35 or NR35R36; R4, R5 = H, 1-4C alkyl, Fl, Cl, OR32, NR33R34 or CrF2r+1; R10 = CnH2n-Het; Het = 1-9C heteroaryl-N-oxide (opt. substd. by 1-3 F, Cl, CF3, OMe, OH, NH2, NHMe or NMe2); R11, R12 = as R10, H or 1-4C alkyl; R14 = 3-9C cycloalkyl or phenyl (opt. by 1-3 F, Cl, CF3, Me, OMe, NH2, NHMe or NMe2); R11, R12 = as R10, H or 1-4C alkyl; R14 = 3-8C cycloalkyl or phenyl (opt. substd. by 1-3 F, Cl, CF3, Me, OMe, NH2, NHMe or NMe2); X = a bond, O, S or NR28; R22 = 1-8C alkyl, 2-6C alkenyl, CmH2mR29 or CF3; R23, R25, R26 = H or as R22; R24, R27 = H or 1-4C alkyl; or R23 + R24, R26 + R27 = (CH2)4 or (CH2)5 (both opt. with a CH2 replaced by O, S, NH, NMe or N-benzyl); R28 = H or 1-3C alkyl; R29 = 3-7C cycloalkyl or phenyl (opt. mono- or tri-substd. by F, Cl, CF3, Me, OMe or NR30R31; R30, R31 = H or 1-4C alkyl; R35, R36 = H or 1-6C alkyl; or R35 + R36 = (CH2)y (opt with a CH2 replaced by O, S, NH, NMe or N-benzyl); R32-R34 = H or 1-3C alkyl; n, p, u = 0-2; m = 0-4; r = 1-4; q = 0-6; y = 4-7. Also claimed are cpds. of formula (IIIA); A = Cl, OR45, OH, OM or imidazol-1-yl; M = alkali or alkaline earth metal ion; and R45 = 1-8C alkyl or 1-4C alkylphenyl.
Patent NZ-274041-A (NZ)
Title: Substituted 1,4-diaryl-3-aralkyl-azetidin-2-one derivatives and pharmaceutical compositions
Inventor: ROSENBLUM STUART B
IPC: C07D205/08
Filed: 1994-09-14
Abstract: Hydroxy-substd. azetidinone derivs. of formula (I) and their salts are new. Ar1,Ar2 = aryl (opt. substd. by 1-5 gps. R4); Ar3 = aryl (opt. substd. by 1-5 gps. R5); X, Y, Z = CH2, CH(1-6C alkyl) or C(di(1-6C alkyl); R, R2 = OR6, OCOR6, OCOOR9 or OCONR6R7; R1, R3 = H, 1-6C alkyl or aryl; q, r = 0 or 1; m, n, p = 0-4, provided that i) at least one of q and r is 1, and the sum of m, n q and r is 1-6, and ii) when p is 0 and r is 1, the sum of m, q and n is 1-5; R4 = 1-6C alkyl, OR6, OCOR6, OCOR9, O(CH2)sOR6, OCONR6R7, NR6R7, NR6COR7, NR6COOR9, NR9, NR6CONR7R8, NR6CONR7R8, NR6SO2R9, COOR6, CONR6R7, COR6, SO2NR6R7, S(O)tR9, O(CH2)uCOOR6, O(CH2)uCONR6R7, lower alkylCOOR6, CH=CH-COOR6, CF3, CN, NO2 or halogen; R5 = OR6, OCOR6, O(CO)R9, O(CH2)vOR6, -O(CO)NR6R7, NR6R7, NR6COR7, NR6COOR9, NR6COOR9, NR6CONR7R8, NR6SO2R9, COOR6, CONR6R7, COR6, SO2NR6R7, S(O)tR9, -O(CH2)uCOOR6, O(CH2)uCONR6R7, lower alkylCOOR6 or -CH=CH-COOR6; s = 1-5; t = 0-2; u = 1-10; v = 1-5; R6, R7, R8 = H, 1-6C alkyl (opt.substd. with aryl) or aryl; and R9 = 1-6C alkyl (opt. substd. with aryl) or aryl.
Patent NZ-298801-A (NZ)
Title: Thrombolytic agent from Staphlococcus aureus
Inventor: COLLEN DESIRE JOSE
IPC: A61K38/16
Filed: 1996-01-03
Abstract: taphylokinase derivatives showing a reduced immunogenicity as compared to wild-type staphylokinase and having the amino acid sequence as in figure 1 in which one or more amino acids in one or more of the underlined clusters have been replaced by another amino acid thus destroying the corresponding epitope(s). Also claimed is a method for producing staphylokinase derivatives where: a)	the DNA fragment comprising the part of the coding sequence of staphylokinase b)	performing in vitro site directed mutagenesis on the fragment, replacing one or more codons  for wild type amino acids by a codon for another amino acid c)	cloning the mutated DNA fragment in a vector d)	transforming or transfecting a suitable host cell with the vector e)	culturing the host cell under conditions suitable for expressing the DNA vector Finally claimed is the use of these derivatives for treating arterial thrombosis
Patent NZ-319639-A (NZ)
Title: membrane protein p76 of helicobacter pylori
Inventor: LISSOLO LING
IPC: A61P31/04
Filed: 1996-10-04
Abstract: The invention relates to a protein of Helicobacter pylori in a substantially purified form, susceptible of being obtained from a membrane fraction of Helicobacter pylori and of which the molecular weight after electrophoresis on polyacrylamide gel 10 % in the presence of SDS is approximately of 76 kD. Also claimed is a polypeptide derived by mutation or fragmentation from the above protein, a pharmaceutical composition for the prevention of a H. pylori infection, monospecific antibody capable of recognizing a protein above, and a diagnostic method which makes it possible to detect the presence of Helicobacter in a biological sample.
Patent NZ-333213-A (NZ)
Title: Modified live avian polyomavirus vaccine in psittaciformes
Inventor: RITCHIE BRANSON W
IPC: A61K39/12
Filed: 1997-06-04
Abstract: The vaccine is protective against avian polyomavirus infection, particularly in budgerigars, lovebirds and cockatiels.  The vaccine comprises 102 TCID50 to 107 TCID50 of a modified live avian polyomavirus in a pharmaceutically acceptable carrier.
Patent NZ-337519-A (NZ)
Title: Building block with internal space  and apertures in face(s) so that settable material can form keys for external coating
Inventor: SHIRREFF CHRISTOPHER LINCOLN
IPC: E04G9/10
Filed: 1999-08-26
Abstract: The block is hollow and has apertures 8 so that concrete can move through these to form keys for a finishing layer of concrete.
Patent NZ-503068-A (NZ)
Title: Implantable active agent delivery device with back diffusion regulating outlet
Inventor: MAGRUDER JUDY A
IPC: A61M5/145
Filed: 1997-01-15
Abstract: An implantable drug delivery device is provided with a back diffusion-regulating outlet 40 mated with the reservoir 12.  A flow path 36 for the active agent 18 is formed between the mating surfaces of the reservoir and the outlet.  The length, interior cross-sectional shape and area of the flow path provides that the average linear velocity of the active agent flowing out of the reservoir is greater than the linear inward flux of the fluid of the environment into which the device is implanted.  A water swellable agent 20 drives the piston 16 to expel the active agent as water permeates into the device via the semipermeable plug 26.  To prevent the water swellable agent from being released into the body, the back diffusion-regulating outlet will be expelled from the end of the reservoir at a pressure that is less than the maximum osmotic pressure generable by the water swellable agent.
Patent NZ-505912-A (NZ)
Title: Cyclic amide compounds and pharmaceuticals thereof; useful for the inhibition of the production of IgE antibody, and therefore useful for preventing and treating allergic immunological disease
Inventor: ISHIWATA HIROYUKI
IPC: C07D211/34
Filed: 1999-02-16
Abstract: A compound represented by the following general formula (1): A is an idenyl, phenyl, naphthyl, dihydronaphthyl, indolyl, isoindolyl, pyridyl, quinolyl or isoquinolyl group, all of which may be optionally substituted. X is a single bond; a lower alkylene, a divalent residue of a cycloalkane,  a phenylene group,  a divalent residure of pyridine, an imino group, all of which are optionally substituted, or a sulphur atom or an oxygen atom. Y is a single bond, or a lower alkylene, imino or lower alkylimino group; Z is a group of -CH=CH-, -C=C-, -(CH=CH)2-, -C=C-CH=CH- or -CH=CH-C=C-, or a divalent residue of benzene, pyridine, pyrimidine or pyrazine which may be optionally substituted; B is a nitrogen atom or =CH-; and m and n are the same or different from each other and independently an integer of 1 to 4, a salt thereof, or a solvate thereof. Also described is a medicinal composition comprising the compound of formula (1) and a pharmaceutically acceptable carrier. The compound of formula (1) is useful for the treatment of diseases, particularly asthma, atopic dermatitis, allergic rhinitis, inflammatory large bowel disease, contact dermatitis, allergic ophthalmopathy or allergic immunological disease.
Patent NZ-507093-A (NZ)
Title: Methods and means for reducing the phenotypic expression of a nucleic acid of interest in a plant
Inventor: WATERHOUSE PETER MICHAEL
IPC: C12N15/63
Filed: 1999-04-07
Abstract: Methods and means are provided for reducing the phenotypic expression of a nucleic acid of interest in eukaryotic cells, particularly in plant cells, by introducing chimeric genes encoding sense and antisense RNA molecules directed towards the target nucleic acid, which are capable of forming a double stranded RNA region by base-pairing between the regions with the sense and antisense nucleotide sequence or by introducing the RNA molecules themselves.  Preferably, the RNA molecules comprise simultaneously both sense and antisense nucleotide sequence.
Patent NZ-508720-A (NZ)
Title: Resilient containers for hyperpolarized gases
Inventor: DRIEHUYS BASTIAAN
IPC: F17B1/26
Filed: 1999-06-16
Abstract: A resilient multi-layer container is configured to receive a quantity of hyperpolarized noble fluid such as gas and includes a wall with at least two layers, a first layer with a surface which minimizes contact-induced spin-relaxation and a first or second layer which is substantially impermeable to oxygen.  The container is especially suitable for collecting and transporting 3He.  The resilient container can be formed of material layers which are concurrently responsive to pressure such as polymers, deuterated polymers, or metallic films.  The container can include a capillary stem and/or a port or valve isolation means to inhibit the flow of gas from the main volume of the container during transport.  The resilient container can be configured to directly deliver the hyperpolarized noble gas to a target interface by deflating or collapsing the inflated resilient container.  In addition, single layer resilient containers with T1's of above 4 hours for 129Xe and above 6 hours for 3He include materials with selected relaxivity values.  In addition, a bag with a port fitting or valve member and one or more of a capillary stem and port isolation means is configured to minimize the depolarizing effect of the container valve or fitting(s).
Patent NZ-514479-A (NZ)
Title: Mechanically coded filling nozzle with bung cap
Inventor: MURPHY OLLIVER III
IPC: B01J4/00
Filed: 2000-02-23
Abstract: A geometric lockout coupler assembly (120) comprising a probe (200) capable of reversibly moving between an open position and a closed position, the open position permitting fluid to pass through the probe (200); and a bung cup (800) sized and configured to accept the probe (200). The probe (200) further comprises a geometric configuration, which cooperates with the complementarily shaped bung cup (800) to allow fluid to flow through the probe (200) while not permitting other probes to cooperate with the bung cup (800).
Patent NZ-516865-A (NZ)
Title: An animal handling apparatus
Inventor: ROSS TONY ASHLEY
IPC: A01K15/04
Filed: 2002-01-28
Abstract: An animal handling apparatus comprising a treatment area for an animal, wherein said treatment area comprises a cradle to support an animal which is formed from a plurality of spaced apart elongate elements which provide a cradle with a first end and a second open end. The elongate elements are movable about a support means at the first end of the cradle between at least a first raised position in which the cradle is adjacent the loading zone and in which position the cradle holds an animal for treatment and a second release position where the animal is set free from the cradle via the opening.
Patent NZ-521188-A (NZ)
Title: Atvorstatin calcium for inhibiting the formation of osteoclasts and preventing osteoporosis
Inventor: BARAGI VIJAYKUMAR MAHALINGAPPA
IPC: A61K31/366
Filed: 2002-09-04
Abstract: A method for inhibiting the formation of osteoclasts comprising administering a therapeutically effective amount of a statin to a mammal in need thereof as well as pharmaceutical compositions, kits for containing such compositions as well as pharmaceutical compositions comprising a statin are described. The compositions disclosed are useful for treating or preventing a disease state selected from the group consisting of osteoporosis, Paget's disease, osteolysis, hypocalcaemia of malignancy, osteogenesis imperfecta, osteoarthritis, alveolar bone loss, side effects of immunosuppressive therapy, and side effects of chronic glucocorticoid use by inhibiting the formation of osteoclasts.
Patent NZ-524894-A (NZ)
Title: Antisense oligonucleotides against VR1
Inventor: KURRECK JENS
IPC: G01N33/15
Filed: 2001-08-31
Abstract: Antisense oligonucleotides against vanilloid receptor 1 (VR1), corresponding nucleotide constructs, cells containing said nucleotide constructs, pharmaceuticals and diagnostic substances, the use thereof in pain therapy, and a method for diagnosing symptoms related to VR1 and for identifying pain-modulating substances are disclosed.
Patent NZ-525570-A (NZ)
Title: Antimicrobial 2-pyridones, their compositions and uses
Inventor: LEDOUSSAL BENOIT
IPC: C07D455/02
Filed: 2001-12-07
Abstract: Compounds having a structure according to general formula (I), pharmaceutical compositions comprising compounds of formula (I) and the uses of these compositions for treating a microbial infection are disclosed.
Patent NZ-525783-A (NZ)
Title: Tag marking with laser
Inventor: GARDNER MICHAEL STUART
IPC: G06K19/00
Filed: 2001-11-21
Abstract: A tag such an animal ear tag (1) is laser marked with indicia (2). The contrast between the indicia (2) and the surrounding surface of the tag (1) is enhanced by the heated of the indicia following laser marking to a temperature at which the indicia and the surrounding surface have melted. In the preferred embodiment the indicia (2) is provided as a raised surface (3) and with a plurality of spaced apart peaks (4) with gaps (6) therebetween. The heating of the tag (1) is preferably by the application of a hot plate to the indicia surface of the tag and simultaneously or subsequently to the non-indicia surface of the tag.
Patent NZ-526407-A (NZ)
Title: Materials for enhancing staining of biopolymers in matrices
Inventor: WHITNEY SCOTT
IPC: C12Q1/68
Filed: 2001-11-20
Abstract: Disclosed is a method for detecting biopolymers in a matrix wherein the method involves (a) contacting the matrix with a sensitizing reagent comprising one or more optionally substituted heteroaromatic compounds; (b) contacting the matrix with one ore more reduceable metal salts to stain said biopolymer; and (c) detecting the stained biopolymer. Compositions that are useful in these method and kits for carrying out these methods for detecting biopolymers in a matrix are also disclosed.
Patent NZ-527201-A (NZ)
Title: Stable norastemizole formulations comprising coated norastemizole particles
Inventor: REDMON MARTIN P
IPC: A61K/
Filed: 1998-03-25
Abstract: Disclosed are solid pharmaceutical compositions comprising norastemizole, wherein instability is reduced by the use of particles of norastemizole or pharmaceutically acceptable salts coated with an inert coating to form the composition. Suitable inert coatings include methlcellulose, hydroxymethyl cellulose, carboxymethyl cellulose, hydroxypropylmethylcellulose, hydroxypropyl cellulose, hydroxyethylcellulose, methylhydroxyethylcellulose, sodium carboxymethylcellulose and mixtures thereof. Such compositions are useful in the treatment of allergic disorders, particularly allergic rhinitis. (62) Divided out of 517472
Patent NZ-529102-A (NZ)
Title: Illuminated background display apparatus
Inventor: BLACH TOMASZ
IPC: G09F13/02
Filed: 2002-03-27
Abstract: An illuminating display including a transparent substrate (12) in the form of a sheet or slab having an upper face (14), a lower face (16) and a plurality of edge faces. The edge faces are provided with an internally reflective treatment (18) and at least one light source (20) is associated with the substrate, causing a narrow beam of light rays to emanate into the substrate. At least one reflective surface (22) arranged internally, preferably perpendicular to either the upper or lower face, of the substrate to operatively internally reflect light rays (26) from the light source within the substrate. Either (or both) the upper face and the lower face having material (17) in contact therewith for capturing or directing light from within the substrate out of a face. The display may be employed in combination with a liquid crystal display (LCD) assembly.
Patent NZ-529576-A (NZ)
Title: Process for the production of 6,7-dihydroxy steroid compounds by allylic oxidation of steroid-5-ene compounds to steroid-5-ene-7-one compounds followed by hydroboration and oxidation intermediates of this process
Inventor: BURGOYNE DAVID L
IPC: C07J41/00
Filed: 2002-05-22
Abstract: Disclosed is a method of producing 6,7-dihydroxy steroid compounds, comprising: (a) providing a compound comprising a steroid carbon skeleton and an alpha,beta-unsaturated ketone moiety of formula (I), (b) contacting the compound of (a) to a hydroboration reagent to form a hydroboration product, followed by oxidative work-up, and (c) forming a product comprising a steroid carbon skeleton and two hydroxyl groups as present in a compound of formula (II).